United States Castration-Resistant Prostate Cancer Therapeutics Industry 2016 Deep Market Research Report
- QYR609616
- 139 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Castration-Resistant Prostate Cancer Therapeutics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Castration-Resistant Prostate Cancer Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 148 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Castration-Resistant Prostate Cancer Therapeutics
1.1.1 Definition of Castration-Resistant Prostate Cancer Therapeutics
1.1.2 Specifications of Castration-Resistant Prostate Cancer Therapeutics
1.2 Classification of Castration-Resistant Prostate Cancer Therapeutics
1.3 Applications of Castration-Resistant Prostate Cancer Therapeutics
1.4 Industry Chain Structure of Castration-Resistant Prostate Cancer Therapeutics
1.5 Industry Overview of Castration-Resistant Prostate Cancer Therapeutics
1.6 Industry Policy Analysis of Castration-Resistant Prostate Cancer Therapeutics
1.7 Industry News Analysis of Castration-Resistant Prostate Cancer Therapeutics
2 Manufacturing Cost Structure Analysis of Castration-Resistant Prostate Cancer Therapeutics
2.1 Bill of Materials (BOM) of Castration-Resistant Prostate Cancer Therapeutics
2.2 BOM Price Analysis of Castration-Resistant Prostate Cancer Therapeutics
2.3 Labor Cost Analysis of Castration-Resistant Prostate Cancer Therapeutics
2.4 Depreciation Cost Analysis of Castration-Resistant Prostate Cancer Therapeutics
2.5 Manufacturing Cost Structure Analysis of Castration-Resistant Prostate Cancer Therapeutics
2.6 Manufacturing Process Analysis of Castration-Resistant Prostate Cancer Therapeutics
2.7 United States Price, Cost and Gross of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Castration-Resistant Prostate Cancer Therapeutics Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015
4 Production Analysis of Castration-Resistant Prostate Cancer Therapeutics by Regions, Type, and Applications
4.1 United States Production of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
4.2 United States Production of Castration-Resistant Prostate Cancer Therapeutics by Type 2011-2016
4.3 United States Sales of Castration-Resistant Prostate Cancer Therapeutics by Applications 2011-2016
4.4 Price Analysis of United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
5 Consumption Volume and Consumption Value Analysis of Castration-Resistant Prostate Cancer Therapeutics by Regions
5.1 United States Consumption Volume of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
5.2 United States Consumption Value of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
5.3 United States Consumption Price Analysis of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
6 Analysis of Castration-Resistant Prostate Cancer Therapeutics Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Castration-Resistant Prostate Cancer Therapeutics 2014-2015
6.3 Sales Overview of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
6.4 Supply, Consumption and Gap of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
6.5 Import, Export and Consumption of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
7 Analysis of Castration-Resistant Prostate Cancer Therapeutics Industry Key Manufacturers
7.1 Johnson & Johnson
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Dendreon Corporation
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Sanofi
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Bayer
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Astellas Pharma Inc
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
…
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Castration-Resistant Prostate Cancer Therapeutics Product Types
8.5 Market Share Analysis of Different Castration-Resistant Prostate Cancer Therapeutics Price Levels
8.6 Gross Margin Analysis of Different Castration-Resistant Prostate Cancer Therapeutics Applications
9 Marketing Trader or Distributor Analysis of Castration-Resistant Prostate Cancer Therapeutics
9.1 Marketing Channels Status of Castration-Resistant Prostate Cancer Therapeutics
9.2 Traders or Distributors of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Castration-Resistant Prostate Cancer Therapeutics
9.4 United States Import, Export and Trade Analysis of Castration-Resistant Prostate Cancer Therapeutics
10 Development Trend of Castration-Resistant Prostate Cancer Therapeutics Industry 2016-2021
10.1 Capacity and Production Overview of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
10.2 Production Market Share by Product Types of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
10.3 Sales and Sales Revenue Overview of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
10.4 United States Sales of Castration-Resistant Prostate Cancer Therapeutics by Applications 2016-2021
10.5 Import, Export and Consumption of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
11 Industry Chain Suppliers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
11.1 Major Raw Materials Suppliers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
11.2 Manufacturing Equipment Suppliers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
11.3 Major Players of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
11.4 Key Consumers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
11.5 Supply Chain Relationship Analysis of Castration-Resistant Prostate Cancer Therapeutics
12 New Project Investment Feasibility Analysis of Castration-Resistant Prostate Cancer Therapeutics
12.1 New Project SWOT Analysis of Castration-Resistant Prostate Cancer Therapeutics
12.2 New Project Investment Feasibility Analysis of Castration-Resistant Prostate Cancer Therapeutics
13 Conclusion of the United States Castration-Resistant Prostate Cancer Therapeutics Industry 2016 Market Research Report
Figure Picture of Castration-Resistant Prostate Cancer Therapeutics
Table Product Specifications of Castration-Resistant Prostate Cancer Therapeutics
Table Classification of Castration-Resistant Prostate Cancer Therapeutics
Figure United States Sales Market Share of Castration-Resistant Prostate Cancer Therapeutics by Product Types in 2015
Table Applications of Castration-Resistant Prostate Cancer Therapeutics
Figure United States Sales Market Share of Castration-Resistant Prostate Cancer Therapeutics by Applications in 2015
Figure Industry Chain Structure of Castration-Resistant Prostate Cancer Therapeutics
Table United States Industry Overview of Castration-Resistant Prostate Cancer Therapeutics
Table Industry Policy of Castration-Resistant Prostate Cancer Therapeutics
Table Industry News List of Castration-Resistant Prostate Cancer Therapeutics
Table Bill of Materials (BOM) of Castration-Resistant Prostate Cancer Therapeutics
Table Bill of Materials (BOM) Price of Castration-Resistant Prostate Cancer Therapeutics
Table Labor Cost of Castration-Resistant Prostate Cancer Therapeutics
Table Depreciation Cost of Castration-Resistant Prostate Cancer Therapeutics
Table Manufacturing Cost Structure Analysis of Castration-Resistant Prostate Cancer Therapeutics in 2015
Figure Manufacturing Process Analysis of Castration-Resistant Prostate Cancer Therapeutics
Table United States Price Analysis of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (USD/Unit)
Table United States Cost Analysis of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (USD/Unit)
Table United States Gross Analysis of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Castration-Resistant Prostate Cancer Therapeutics Manufacturers in 2015
Table R&D Status and Technology Source of United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015
Table United States Production of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016 (Unit)
Table United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions in 2014
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions in 2015
Table United States Production of Castration-Resistant Prostate Cancer Therapeutics by Types in 2011-2016 (Unit)
Table United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Type in 2011-2016
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Type in 2014
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Type in 2015
Table United States Sales of Castration-Resistant Prostate Cancer Therapeutics by Applications 2011-2016 (Unit)
Table United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Applications 2011-2016
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Applications in 2014
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Applications in 2015
Table Price Comparison of United States Castration-Resistant Prostate Cancer Therapeutics Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Table United States Consumption Volume of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
Figure United States Consumption Volume Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions in 2014
Figure United States Consumption Volume Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions in 2015
Table United States Consumption Value of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016
Figure United States Consumption Value Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions in 2014
Figure United States Consumption Value Market Share of Castration-Resistant Prostate Cancer Therapeutics by Regions in 2015
Table Consumption Price of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (Unit)
Table United States Capacity Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (Unit)
Table United States Production Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (Unit)
Table United States Sales Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Figure United States Capacity Utilization Rate of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Figure United States Production Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers in 2014
Figure United States Production Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers in 2015
Figure United States Sales Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers in 2014
Figure United States Sales Market Share of Major Castration-Resistant Prostate Cancer Therapeutics Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Table United States Supply, Consumption and Gap of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (Unit)
Table United States Import, Export and Consumption of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (Unit)
Table Price of United States Castration-Resistant Prostate Cancer Therapeutics Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Castration-Resistant Prostate Cancer Therapeutics Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Castration-Resistant Prostate Cancer Therapeutics 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Castration-Resistant Prostate Cancer Therapeutics 2011-2016
Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Castration-Resistant Prostate Cancer Therapeutics Picture and Specifications of Johnson & Johnson
Table Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit) and Growth Rate of Johnson & Johnson 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Production (Unit) and United States Market Share of Johnson & Johnson 2011-2016
Table Johnson & Johnson Castration-Resistant Prostate Cancer Therapeutics SWOT Analysis
Table Dendreon Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Castration-Resistant Prostate Cancer Therapeutics Picture and Specifications of Dendreon Corporation
Table Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dendreon Corporation 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit) and Growth Rate of Dendreon Corporation 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Production (Unit) and United States Market Share of Dendreon Corporation 2011-2016
Table Dendreon Corporation Castration-Resistant Prostate Cancer Therapeutics SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Castration-Resistant Prostate Cancer Therapeutics Picture and Specifications of Sanofi
Table Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit) and Growth Rate of Sanofi 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Production (Unit) and United States Market Share of Sanofi 2011-2016
Table Sanofi Castration-Resistant Prostate Cancer Therapeutics SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Castration-Resistant Prostate Cancer Therapeutics Picture and Specifications of Bayer
Table Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit) and Growth Rate of Bayer 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Production (Unit) and United States Market Share of Bayer 2011-2016
Table Bayer Castration-Resistant Prostate Cancer Therapeutics SWOT Analysis
Table Astellas Pharma Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Castration-Resistant Prostate Cancer Therapeutics Picture and Specifications of Astellas Pharma Inc
Table Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Astellas Pharma Inc 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Capacity (Unit), Production (Unit) and Growth Rate of Astellas Pharma Inc 2011-2016
Figure Castration-Resistant Prostate Cancer Therapeutics Production (Unit) and United States Market Share of Astellas Pharma Inc 2011-2016
Table Astellas Pharma Inc Castration-Resistant Prostate Cancer Therapeutics SWOT Analysis
Table Castration-Resistant Prostate Cancer Therapeutics Price by Regions 2011-2016
Table Castration-Resistant Prostate Cancer Therapeutics Price by Product Types 2011-2016
Table Castration-Resistant Prostate Cancer Therapeutics Price by Companies 2011-2016
Table Castration-Resistant Prostate Cancer Therapeutics Gross Margin by Companies 2011-2016
Table Price Comparison of Castration-Resistant Prostate Cancer Therapeutics by Regions 2011-2016 (USD/Unit)
Table Price of Different Castration-Resistant Prostate Cancer Therapeutics Product Types (USD/Unit)
Table Market Share of Different Castration-Resistant Prostate Cancer Therapeutics Price Level
Table Gross Margin of Different Castration-Resistant Prostate Cancer Therapeutics Applications
Table Marketing Channels Status of Castration-Resistant Prostate Cancer Therapeutics
Table Traders or Distributors of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Castration-Resistant Prostate Cancer Therapeutics (USD/Unit) in 2015
Table United States Import, Export, and Trade of Castration-Resistant Prostate Cancer Therapeutics (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
Figure United States Capacity Utilization Rate of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
Table United States Castration-Resistant Prostate Cancer Therapeutics Production by Type 2016-2021 (Unit)
Table United States Castration-Resistant Prostate Cancer Therapeutics Production Market Share by Type 2016-2021
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
Figure United States Sales of Castration-Resistant Prostate Cancer Therapeutics by Applications 2016-2021 (Unit)
Table United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Applications 2016-2021
Figure United States Production Market Share of Castration-Resistant Prostate Cancer Therapeutics by Applications in 2021
Table United States Production, Import, Export and Consumption of Castration-Resistant Prostate Cancer Therapeutics 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Castration-Resistant Prostate Cancer Therapeutics 2016-2021
Table Major Raw Materials Suppliers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
Table Manufacturing Equipment Suppliers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
Table Major Players of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
Table Key Consumers of Castration-Resistant Prostate Cancer Therapeutics with Contact Information
Table Supply Chain Relationship Analysis of Castration-Resistant Prostate Cancer Therapeutics
Table New Project SWOT Analysis of Castration-Resistant Prostate Cancer Therapeutics
Table New Project Investment Feasibility Analysis of Castration-Resistant Prostate Cancer Therapeutics
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
